
Arthroplasty
Continuous femoral nerve blockade versus patient-controlled analgesia following TKA
Hong Kong Med J. 2014 Feb;20(1):45-51. doi: 10.12809/hkmj133899. Epub 2013 Sep 11.60 patients undergoing unilateral elective total knee arthroplasty under spinal anaesthesia were randomized to undergo a newly-proposed multidisciplinary postoperative treatment protocol involving multimodal analgesia and either continuous femoral nerve blockade (CFNB) or conventional patient-controlled analgesia (PCA). The purpose of this study was to compare clinical and functional outcomes associated with these two treatment approaches. Results indicated that the CFNB group displayed significantly lower total morphine consumption on postoperative days 0 and 1, experienced fewer instances of opioid-related side-effects, and had high patient satisfaction regarding pain control. The number of patients who underwent first mobilization on postoperative day 1 was significantly higher in the CFNB group. Pain at rest and during mobilization, patient satisfaction regarding the total knee replacement pathway used in this study, hospital stay, the incidence of complications and Knee Society Scores up to 6 months were similar between groups.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.